BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23582989)

  • 1. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
    Tse DT; Kossler AL; Feuer WJ; Benedetto PW
    Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
    Tse DT; Benedetto PW; Tse BC; Feuer WJ
    Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT
    Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric adenoid cystic carcinoma of the lacrimal gland treated with intra-arterial cytoreductive chemotherapy.
    Eneh A; Parsa K; Wright KW; Strube YN
    J AAPOS; 2015 Jun; 19(3):272-4. PubMed ID: 25890838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic Observations of Eyes in Exenterated Orbits After Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland.
    Liao SD; Erickson BP; Kapila N; Dubovy SR; Tse DT
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3):274-279. PubMed ID: 32890114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
    Costa PA; Tse DT; Benedetto P
    Oncologist; 2024 Mar; 29(3):263-269. PubMed ID: 38227581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.
    Meldrum ML; Tse DT; Benedetto P
    Arch Ophthalmol; 1998 Mar; 116(3):315-21. PubMed ID: 9514484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma?
    Esmaeli B
    Ophthalmology; 2014 Jan; 121(1):e7-e8. PubMed ID: 24268857
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
    Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland.
    Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL
    Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
    Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
    Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
    Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
    Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
    Han J; Kim YD; Woo KI; Sobti D
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoid cystic carcinoma of the lacrimal gland: rare … lethal … cured?
    Bradley EA; Bradley DJ
    Ophthalmology; 2013 Jul; 120(7):1311-2. PubMed ID: 23823505
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male.
    Falcone MM; Tran KD; Tavakoli M; Ortiz DF; Barredo JC; Lee WW
    Orbit; 2017 Dec; 36(6):448-451. PubMed ID: 28738175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Neoadjuvant Intra-arterial Chemotherapy in Lacrimal Gland Adenoid Cystic Carcinoma: A Histological Correlation Using Apoptotic Tumor Markers.
    Maniar A; Saqi A; Troob SH; Belinsky I; Charles NC; Gobin YP; Marr BP
    Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):e28-e33. PubMed ID: 34652309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
    Yang J; Zhou C; Wang Y; Fan X; Jia R
    BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.
    Esmaeli B; Ahmadi MA; Youssef A; Diba R; Amato M; Myers JN; Kies M; El-Naggar A
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):22-6. PubMed ID: 14752305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.